Brightworth Abbott Laboratories Transaction History

Brightworth

$933 Million
Q3 2022

A detailed history of Brightworth transactions in Abbott Laboratories stock. As of the latest transaction made, Brightworth holds 93,901 shares of ABT stock, worth $11 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

93,901

Previous 92,840 1.14%

Holding current value

$11 Million

Previous $10.1 Million 9.92%

% of portfolio

0.97%

Previous 1.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $102,662 - $118,863	1,061 Added 1.14%	93,901 $9.09 Million
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $13,064 - $15,791	128 Added 0.14%	92,840 $10.1 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $151,532 - $184,784	1,329 Added 1.45%	92,712 $11 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $153,423 - $187,858	1,328 Added 1.47%	91,383 $12.9 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $37,097 - $41,041	318 Added 0.35%	90,055 $10.6 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $568,198 - $668,850	5,371 Added 6.37%	89,737 $10.4 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $506,759 - $597,038	4,656 Added 5.84%	84,366 $10.1 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $26,145 - $28,490	-249 Reduced 0.31%	79,710 $8.73 Million
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $130,770 - $158,810	1,427 Added 1.82%	79,959 $8.7 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $47,396 - $60,662	-619 Reduced 0.78%	78,532 $7.18 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $131,105 - $191,711	2,087 Added 2.71%	79,151 $6.25 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $17,652 - $25,812	-281 Reduced 0.36%	77,064 $6.69 Million
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $208,758 - $232,396	2,659 Added 3.56%	77,345 $6.72 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $132,990 - $144,202	1,625 Added 2.22%	74,686 $6.25 Million
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $132,058 - $154,020	1,812 Added 2.54%	73,061 $6.14 Million
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $142,505 - $172,289	2,152 Added 3.11%	71,249 $5.7 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $121,417 - $137,548	-1,852 Reduced 2.61%	69,097 $5 Million
Q3 2018 Oct 25, 2018	BUY	$60.81 - $73.36 $106,356 - $128,306	1,749 Added 2.53%	70,949 $5.21 Million
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $203,394 - $224,486	3,533 Added 5.38%	69,200 $4.22 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $2.46 Million - $2.78 Million	43,648 Added 198.23%	65,667 $3.94 Million
Q4 2017 Jan 24, 2018	BUY	$53.68 - $57.47 $335,607 - $359,302	6,252 Added 39.65%	22,019 $1.26 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $757,762 - $845,741	15,767	15,767 $841,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brightworth, based on Form 13F filings with the SEC.

News

Stay updated on Brightworth with notifications on news.

Account